6-32107786-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001365276.2(TNXB):​c.-9+1395A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.493 in 151,772 control chromosomes in the GnomAD database, including 18,824 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.49 ( 18824 hom., cov: 30)

Consequence

TNXB
NM_001365276.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0510

Publications

34 publications found
Variant links:
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome due to tenascin-X deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Illumina, PanelApp Australia, Orphanet
  • familial vesicoureteral reflux
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • vesicoureteral reflux 8
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.642 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001365276.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TNXB
NM_001365276.2
MANE Select
c.-9+1395A>G
intron
N/ANP_001352205.1
TNXB
NM_001428335.1
c.-9+1395A>G
intron
N/ANP_001415264.1
TNXB
NM_019105.8
c.-9+1395A>G
intron
N/ANP_061978.6

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TNXB
ENST00000644971.2
MANE Select
c.-9+1395A>G
intron
N/AENSP00000496448.1
TNXB
ENST00000479795.1
TSL:1
c.-9+1395A>G
intron
N/AENSP00000418248.1
TNXB
ENST00000442721.1
TSL:1
c.-9+7208A>G
intron
N/AENSP00000389946.1

Frequencies

GnomAD3 genomes
AF:
0.493
AC:
74830
AN:
151654
Hom.:
18824
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.452
Gnomad AMI
AF:
0.643
Gnomad AMR
AF:
0.493
Gnomad ASJ
AF:
0.651
Gnomad EAS
AF:
0.521
Gnomad SAS
AF:
0.663
Gnomad FIN
AF:
0.553
Gnomad MID
AF:
0.650
Gnomad NFE
AF:
0.484
Gnomad OTH
AF:
0.520
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.493
AC:
74875
AN:
151772
Hom.:
18824
Cov.:
30
AF XY:
0.502
AC XY:
37223
AN XY:
74162
show subpopulations
African (AFR)
AF:
0.452
AC:
18711
AN:
41360
American (AMR)
AF:
0.493
AC:
7515
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.651
AC:
2254
AN:
3462
East Asian (EAS)
AF:
0.521
AC:
2683
AN:
5152
South Asian (SAS)
AF:
0.661
AC:
3172
AN:
4798
European-Finnish (FIN)
AF:
0.553
AC:
5818
AN:
10526
Middle Eastern (MID)
AF:
0.620
AC:
181
AN:
292
European-Non Finnish (NFE)
AF:
0.484
AC:
32864
AN:
67918
Other (OTH)
AF:
0.519
AC:
1091
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1915
3829
5744
7658
9573
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
688
1376
2064
2752
3440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.459
Hom.:
11809
Bravo
AF:
0.486
Asia WGS
AF:
0.590
AC:
2055
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
2.2
DANN
Benign
0.72
PhyloP100
-0.051
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs429150; hg19: chr6-32075563; API